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Introduction
This issue of Kidney International contains reviews
and abstracts on current research presented at the In-
ternational Society of Nephrology-sponsored Forefronts
in Nephrology meeting on “Stem Cell and Regeneration
of the Kidney” which took place at Karuizawa Prince
Hotel, Karuizawa, Japan, on January 20–22, 2005. The
purpose of the meeting was to bring together leading sci-
entists from the renal and nonrenal communities whose
interests focus on the stem cell and regeneration of vari-
ous organs. Thirty-one invited speakers from the United
States, Austria, Germany, France, Italy, the United
Kingdom, Sweden, and Japan and 123 scientists partic-
ipated in the meeting. This meeting encompassed four
different themes: neural stem cells and central nervous
system repair, stem cells of heart and vessel, kidney
development and regeneration, and new horizons of
kidney transplantation. The invited speakers certainly
provided cutting-edge information and insights into
molecular mechanism of the renal development and
regeneration.
Hideyuki Okano opened the meeting with a presen-
tation of the considerable impact of regeneration of the
damaged spinal cord by injection of neural progenitor
cells isolated from fetal brain. It has long been thought
that functional regeneration of the injured central ner-
vous system is impossible, as Santiago Ramony Cajal de-
scribed in the early 20th century, “once the development
was ended, the fonts of growth and regeneration. . . dried
up irrevocably.” However, he showed a mouse, once crip-
pled by spinal cord injury, walking because of neuronal
cell therapy. In addition, he described the functional anal-
ysis of Musashi, who described a transcriptional repressor
binding to RNA in neural stem cells, which are strongly
expressed in neural precursor cells, including central ner-
vous system stem cells.
Olle Lindvall dicussed a clinical application of stem
cell therapy to Parkinson’s disease. His laboratory trans-
planted fetal human dopamine neurons, which improved
two thirds of grafted patients, and provided partial recov-
ery of motor function. He stressed that some complica-
tions disturbing the cell therapy, such as immune reaction
and tumorigenesis, need to be improved.
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The stem cell research and application to the pre-
clinical and clinical studies seem to be far advanced in
cardiovascular field. In adult rats, cardiac stem cells
and mesenchymal stem cells of bone marrow con-
tribute to self-renewing and regeneration. It was reported
that insulin-like growth factor-1 (IGF-1), which reduced
inflammatory response by modulating inflammatory
cytokines in injured heart, accelerated cardiac muscle re-
generation. The transplantation of the human endothe-
lial progenitor cells facilitated salvage of limb vasculature
and perfusion in nude mice with hind limb ischemia.
In the differential development of the artery and vein,
chicken ovalbumin upstream promoter-transcription
factor II (COUP-TFII) plays a critical role in the de-
velopment of the vein by using COUP-TFII−/− mice.
COUP-TFII inhibits NP-1, an upstream regulator of
Notch signaling, and induces EphB4, which develop the
vein. Overall, many hints of research could be learned
from the recent research in cardiology.
The research field regarding the stem cell of the kid-
ney is relatively uncultivated compared with the other or-
gans and the researchers obtained different results mainly
from the methodologic difference. However, the develop-
mental research of the kidney steadily progressed during
the last 10 years. Andrew P. McMahon demonstrated a
series of experiments regarding renal tubular progenitor
cells and vascular progenitor cells. He also presented the
Kidney Molecular Atlas Project (KMAR) that is aimed to
provide a detailed map of the expression of all transcrip-
tional regulators, signaling factors, and their receptors in
the developing mouse kidney. Several important factors
for renal development, such as hepatocyte nuclear factor
(HNF)-1b , Notch signaling pathway, Sall family, and glial
cell line–derived neurotrophic factor (GDNF)-inducible
transcription factor, were also discussed.
Several papers concerning stem cell of the kidney were
reported at the conference. The rKS56 cells, isolated renal
tubular progenitor cells from S3, possesses characteris-
tics of self-renewal, multiplasticity, and direct contribu-
tion to tissue-repair. The side population cells isolated
from kidney and the endothelial progenitor cells may be
useful for the cell therapy of the acute renal failure, al-
though the contribution of bone marrow–derived cells
was limited in the repair of the ischemically injured kid-
ney. The potential of cell therapy for Alport syndrome by
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use of the endothelial progenitor cell was also suggested.
The application of fetal organs into adult omentum was
presented and renal metanephroi transplanted into ani-
mal hosts underwent differentiation, growth, became vas-
cularized by blood vessels from host origin, and exhibited
excretory function.
Xenotransplantation may have a potential to alleviate
the worldwide critical shortage of donor organs. The ma-
jor barrier of xenotransplantation is superacute rejection
by expression of glycoprotein on the endothelial cells. The
a-1,3, galactosyltransferase knockout (GalT KO) pig was
generated for inhibition of superacute rejection and the
simultaneous transplantation of the GalT KO kidney and
the thymus lobe was performed to a baboon. The baboon
lived more than 2 months from the cotransplantation.
This result implies that the first barrier of superacute re-
jection in the xenotransplantation might be overcome by
GalT KO and thymic lobe transplantation. It was also
reported that hepatocyte growth factor (HGF) reduced
the allograft injury by use of the immunosuppressant, in
particular the calcineurin inhibitor.
Finally, Jeffery Platt closed the forum with wonderful
closing lecture regarding a potential application of nu-
clear cloning to kidney regeneration. He concluded that
the ideal renal replacement therapy is a combination of
the stem cell, nuclear cloning, organogenesis, and xeno-
transplantation.
We feel the meeting was very well organized and
successful in stimulating and encouraging the young
nephrologists for stem cell research. We hope that these
proceedings will provide the readers of Kidney Interna-
tional with our current understanding of the stem cell and
regeneration of the kidney. The organizers are grateful
to the many scientists who contributed their papers for
this issue. We thank the International Society of Nephrol-
ogy, the Kidney Foundation Japan, and the Federation
of Pharmaceutical Manufacturer’s Associations of Japan
for generously supporting this meeting in Karuizawa and
the editor of Kidney International for the opportunity to
publish this work.
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